Chemotherapy Decision-Making and Survival Outcomes in Older Women With Early Triple-Negative Breast Cancer: Evidence From Real-World Practice

類似資料

• Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy
  著者:: Meiying Li, 等
  出版事項: (2018-01-01)
• The association between early-onset cardiac events caused by neoadjuvant or adjuvant chemotherapy in triple-negative breast cancer patients and some novel autophagy-related polymorphisms in their genomic DNA: a real-world study
  著者:: Binliang Liu, 等
  出版事項: (2018-12-01)
• Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients
  著者:: Guo, Jihong, 等
  出版事項: (2019)
• Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making
  著者:: Lian, Chen-Lu, 等
  出版事項: (2021)
• Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy
  著者:: Li, Meiying, 等
  出版事項: (2018)